quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:35:28·70d
SECFiling
CRISPR Therapeutics AG logo

CRISPR Therapeutics AG filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

CRSP· CRISPR Therapeutics AG
Health Care
Original source

Companies

  • CRSP
    CRISPR Therapeutics AG
    Health Care

Recent analyst ratings

  • Sep 18UpdateAnalyst$70.00
  • Feb 14UpdateEvercore ISI$99.00
  • Feb 12UpdateTD Cowen$35.00
  • Feb 3UpdateH.C. Wainwright$65.00
  • Aug 6UpdateNeedham$84.00
  • Aug 2UpdateRodman & Renshaw$90.00

Related

  • SEC2d
    SEC Form DEFA14A filed by CRISPR Therapeutics AG
  • SEC2d
    SEC Form DEF 14A filed by CRISPR Therapeutics AG
  • PR16d
    CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
  • SEC21d
    SEC Form PRE 14A filed by CRISPR Therapeutics AG
  • PR24d
    Legendary Investors are Rotating Capital into AI Powered Biotech
  • INSIDER30d
    SEC Form 4 filed by Kasinger James R.
  • INSIDER30d
    SEC Form 4 filed by Kulkarni Samarth
  • INSIDER30d
    SEC Form 4 filed by Prasad Raju
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022